scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00213-016-4329-3 |
P698 | PubMed publication ID | 27241709 |
P2093 | author name string | Paul J Fletcher | |
Wayne E Pratt | |||
Guy A Higgins | |||
Cam MacMillan | |||
Leo B Silenieks | |||
Everett B Altherr | |||
P2860 | cites work | Lorcaserin, a 5-HT(2C) receptor agonist, reduces body weight by decreasing energy intake without influencing energy expenditure | Q24611940 |
Obesity and addiction: neurobiological overlaps | Q26827446 | ||
Inactivation of the nucleus accumbens core or medial shell attenuates reinstatement of sugar-seeking behavior following sugar priming or exposure to food-associated cues | Q28539522 | ||
The serotonin 2C receptor agonist Ro-60-0175 attenuates effects of nicotine in the five-choice serial reaction time task and in drug discrimination | Q28576908 | ||
Serotonin 2C receptor activates a distinct population of arcuate pro-opiomelanocortin neurons via TRPC channels | Q28585910 | ||
The debate over dopamine's role in reward: the case for incentive salience | Q29618738 | ||
The neuropharmacology of relapse to food seeking: methodology, main findings, and comparison with relapse to drug seeking | Q30479808 | ||
Varieties of impulsivity | Q33767987 | ||
Effects of central 5-hydroxytryptamine depletion on sensitivity to delayed and probabilistic reinforcement | Q33930154 | ||
High trait impulsivity predicts food addiction-like behavior in the rat | Q34068948 | ||
Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors | Q34086043 | ||
Role of serotonin 5-HT2A and 5-HT2C receptors on brain stimulation reward and the reward-facilitating effect of cocaine | Q34122658 | ||
New approaches to the pharmacological treatment of obesity: can they break through the efficacy barrier? | Q34129885 | ||
Area under the curve as a measure of discounting | Q34136600 | ||
The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry | Q34153836 | ||
Impulsivity, compulsivity, and top-down cognitive control | Q34166008 | ||
Serotonin and drug reward: focus on 5-HT2C receptors | Q34277384 | ||
Effects of lisdexamfetamine in a rat model of binge-eating | Q40295381 | ||
Safety and efficacy of lorcaserin: a combined analysis of the BLOOM and BLOSSOM trials | Q41653487 | ||
Determination of discount functions in rats with an adjusting-amount procedure | Q41878692 | ||
The 5-HT₂C receptor agonist, lorcaserin, and the 5-HT₆ receptor antagonist, SB-742457, promote satiety; a microstructural analysis of feeding behaviour. | Q41910031 | ||
The pharmacology of impulsive behaviour in rats: the effects of drugs on response choice with varying delays of reinforcement | Q42551998 | ||
Differential effects of dopaminergic manipulations on risky choice | Q43056112 | ||
Serotonin 2C receptor agonists and the behavioural satiety sequence in mice. | Q43913101 | ||
Nucleus accumbens dopamine and mu-opioid receptors modulate the reinstatement of food-seeking behavior by food-associated cues | Q44057923 | ||
Activation of central melanocortin pathways by fenfluramine | Q44079737 | ||
The 5-HT2A receptor antagonist M100,907 attenuates motor and 'impulsive-type' behaviours produced by NMDA receptor antagonism | Q44540861 | ||
Attentional effects of nicotine and amphetamine in rats at different levels of motivation. | Q44573259 | ||
Fractionating impulsivity: contrasting effects of central 5-HT depletion on different measures of impulsive behavior | Q44822531 | ||
5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion | Q44962619 | ||
Effects of systemic and intra-nucleus accumbens 5-HT2C receptor compounds on ventral tegmental area self-stimulation thresholds in rats. | Q46230494 | ||
Evaluation of chemically diverse 5-HT₂c receptor agonists on behaviours motivated by food and nicotine and on side effect profiles | Q46240693 | ||
Opposing roles for the nucleus accumbens core and shell in cue-induced reinstatement of food-seeking behavior. | Q46596053 | ||
The 5-HT(2C) receptor agonist WAY-163909 decreases impulsivity in the 5-choice serial reaction time test | Q46811288 | ||
A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial | Q46879925 | ||
Impulsive choice and impulsive action predict vulnerability to distinct stages of nicotine seeking in rats | Q46990157 | ||
Acute nicotine increases both impulsive choice and behavioural disinhibition in rats | Q48141419 | ||
Obesity and the four facets of impulsivity | Q48216980 | ||
Central serotonin depletion impairs both the acquisition and performance of a symmetrically reinforced go/no-go conditional visual discrimination | Q48231322 | ||
The Serotonin 2C Receptor Agonist Lorcaserin Attenuates Intracranial Self-Stimulation and Blocks the Reward-Enhancing Effects of Nicotine | Q48276382 | ||
Effect of lesions of the ascending 5-hydroxytryptaminergic pathways on choice between delayed reinforcers | Q48389666 | ||
Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms | Q48559213 | ||
Serotonin2 receptor agonists and serotonergic anorectic drugs affect rats' performance differently in a five-choice serial reaction time task | Q48853977 | ||
Studies to investigate the role of 5-HT(2C) receptors on cocaine- and food-maintained behavior. | Q51372657 | ||
The 5-HT(1A) receptor agonist 8-OH-DPAT reduces rats' accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task: role of presynaptic 5-HT(1A) receptors. | Q52026882 | ||
Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task. | Q52144163 | ||
Similarities in the action of Ro 60-0175, a 5-HT2C receptor agonist, and d-fenfluramine on feeding patterns in the rat | Q60054744 | ||
Reduced satiating effect of d -fenfluramine in serotonin 5-HT 2C receptor mutant mice | Q60054745 | ||
The effects of d -amphetamine, chlordiazepoxide, α-flupenthixol and behavioural manipulations on choice of signalled and unsignalled delayed reinforcement in rats | Q60632122 | ||
The mysterious motivational functions of mesolimbic dopamine. | Q34310894 | ||
Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity | Q34404395 | ||
Role of serotonin(2C) receptors in the control of brain dopaminergic function | Q34558814 | ||
CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity | Q34562888 | ||
Opposing effects of 5-HT(2A) and 5-HT(2C) receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test | Q34659207 | ||
Multicenter, placebo-controlled trial of lorcaserin for weight management | Q34660152 | ||
Reward mechanisms in obesity: new insights and future directions | Q34674976 | ||
Discovery and structure-activity relationship of (1R)-8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine (Lorcaserin), a selective serotonin 5-HT2C receptor agonist for the treatment of obesity | Q34728055 | ||
Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization | Q34746665 | ||
Selective serotonin 5-HT(2C) receptor activation suppresses the reinforcing efficacy of cocaine and sucrose but differentially affects the incentive-salience value of cocaine- vs. sucrose-associated cues | Q35046675 | ||
Characterization of the 5-HT2C receptor agonist lorcaserin on efficacy and safety measures in a rat model of diet-induced obesity | Q35049574 | ||
Fine-tuning serotonin2c receptor function in the brain: molecular and functional implications | Q35072763 | ||
Feeding and reward: perspectives from three rat models of binge eating | Q35093247 | ||
Effects of the combination of wheel running and atomoxetine on cue- and cocaine-primed reinstatement in rats selected for high or low impulsivity | Q35117860 | ||
The study of food addiction using animal models of binge eating | Q35163002 | ||
Lorcaserin, a 5-HT2C agonist, decreases nicotine self-administration in female rats | Q35188133 | ||
The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders | Q35589965 | ||
Metabolic and hedonic drives in the neural control of appetite: who is the boss? | Q35663456 | ||
The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse control | Q35837700 | ||
Effect of fenfluramine on reinstatement of food seeking in female and male rats: implications for the predictive validity of the reinstatement model | Q35868906 | ||
Choice impulsivity: Definitions, measurement issues, and clinical implications. | Q35951113 | ||
How can drug addiction help us understand obesity? | Q36108706 | ||
Corticostriatal-hypothalamic circuitry and food motivation: integration of energy, action and reward | Q36313629 | ||
Directly Observable Behavioral Effects of Lorcaserin in Rats | Q36316458 | ||
Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors | Q36509808 | ||
The use of the reinstatement model to study relapse to palatable food seeking during dieting | Q37203397 | ||
Systemic treatment with D-fenfluramine, but not sibutramine, blocks cue-induced reinstatement of food-seeking behavior in the rat. | Q37366803 | ||
Effects of amphetamine and methylphenidate on delay discounting in rats: interactions with order of delay presentation. | Q37424552 | ||
Principles of motivation revealed by the diverse functions of neuropharmacological and neuroanatomical substrates underlying feeding behavior | Q37543156 | ||
Parallel, redundant circuit organization for homeostatic control of feeding behavior | Q37675451 | ||
New drug targets for the treatment of obesity. | Q37886661 | ||
What is the prognosis for new centrally-acting anti-obesity drugs? | Q37982154 | ||
The neurobiological underpinnings of obesity and binge eating: a rationale for adopting the food addiction model | Q38055594 | ||
Food-related impulsivity in obesity and binge eating disorder--a systematic review. | Q38075166 | ||
The role of impulsivity in relapse vulnerability. | Q38086664 | ||
Update on obesity pharmacotherapy | Q38196951 | ||
5-hydroxytryptamine medications for the treatment of obesity | Q38449992 | ||
P433 | issue | 14 | |
P921 | main subject | obesity | Q12174 |
P1104 | number of pages | 16 | |
P304 | page(s) | 2841-2856 | |
P577 | publication date | 2016-05-30 | |
P1433 | published in | Psychopharmacology | Q1422802 |
P1476 | title | Lorcaserin and CP-809101 reduce motor impulsivity and reinstatement of food seeking behavior in male rats: Implications for understanding the anti-obesity property of 5-HT2C receptor agonists | |
P478 | volume | 233 |
Q36291168 | Aggressive clinical approach to obesity improves metabolic and clinical outcomes and can prevent bariatric surgery: a single center experience |
Q33710789 | Behavioral Effects of a Novel Benzofuranyl-Piperazine Serotonin-2C Receptor Agonist Suggest a Potential Therapeutic Application in the Treatment of Obsessive-Compulsive Disorder |
Q50227324 | Choice between delayed food and immediate opioids in rats: treatment effects and individual differences |
Q92932843 | Hypophagia induced by hindbrain serotonin is mediated through central GLP-1 signaling and involves 5-HT2C and 5-HT3 receptor activation |
Q97883048 | Lorcaserin Alters Serotonin and Noradrenaline Tissue Content and Their Interaction With Dopamine in the Rat Brain |
Q50046451 | Neural circuits of eating behaviour: Opportunities for therapeutic development. |
Q38924615 | Neurotransmitters: The Critical Modulators Regulating Gut-Brain Axis. |
Q38664308 | Pharmacotherapies for decreasing maladaptive choice in drug addiction: Targeting the behavior and the drug |
Q47588598 | Role of impulsivity and reward in the anti-obesity actions of 5-HT2C receptor agonists |
Q89977069 | Serotonin in Animal Cognition and Behavior |
Q37635780 | Serotonin receptors in depression: from A to B. |
Search more.